Gα12 is required for renal cystogenesis induced by Pkd1 inactivation

Area of Science:

• Molecular Biology
• Genetics
• Nephrology

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is primarily caused by mutations in the PKD1 gene, encoding polycystin-1 (PC1).
• The precise downstream signaling pathways regulated by PC1 in ADPKD pathogenesis remain incompletely elucidated.
• Understanding these pathways is critical for developing targeted therapeutic strategies for ADPKD.

Purpose of the Study:

• To investigate the role of Gα12 in renal cystogenesis associated with Pkd1 mutations.
• To determine if Gα12 is a necessary component of the signaling cascade leading to cyst formation in a mouse model of ADPKD.
• To explore the specific cellular mechanisms by which Gα12 influences cyst development.

Main Methods:

• Utilized a mouse model with inducible Pkd1 deletion (Mx1Cre⁺Pkd1^f/f).
• Generated mice with combined Pkd1 and Gα12 knockout (Mx1Cre⁺Pkd1^f/fGα12^-/-) and compared them to controls (Mx1Cre⁺Pkd1^f/fGα12^+/+).
• Assessed kidney structure and function, as well as hepatic phenotypes, in knockout and control mice.

Main Results:

• Mice with Pkd1 knockout developed multiple kidney cysts, while those with simultaneous Pkd1 and Gα12 knockout showed no renal abnormalities.
• Gα12 knockout prevented cystogenesis in the Pkd1-deficient mice, indicating Gα12 is essential for this process.
• Pdk1 knockout led to increased Gα12 activation, impairing cell-matrix and cell-cell adhesion by affecting focal adhesion and E-cadherin.

Conclusions:

• Gα12 is genetically required for renal cyst development induced by Pkd1 mutation in ADPKD.
• The role of Gα12 in cystogenesis appears to be kidney-specific, as hepatic cysts were observed in some Gα12-deficient mice.
• These findings identify Gα12 as a key mediator in Pkd1-associated ADPKD, offering a potential therapeutic target.